Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Vocci

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Addiction (Abingdon, England)|June 8, 2012
Commentary on Elkashef et al. (2012): just enough efficacy for a second lookFrank Vocci
Addiction Biology|July 10, 2003
Biological markers of cocaine addiction: implications for medications developmentAhmed Elkashef, Frank Vocci
Pharmacology & Therapeutics|August 9, 2005
Medications development: successes and challengesFrank Vocci, Walter Ling
Journal of Addictive Diseases|August 7, 2008
Clinical management of drug addicts infected with human immunodeficiency virus and hepatitis C virusJag H Khalsa, Frank Vocci
Journal of Dual Diagnosis|September 28, 2011
Medications Development for the Treatment of Nicotine Dependence in Individuals with SchizophreniaIvan D Montoya, Frank Vocci
Current Psychiatry Reports|September 23, 2008
Novel medications to treat addictive disordersIván D Montoya, Frank Vocci
American Journal of Infectious Diseases|August 7, 2007
Hormonal and Metabolic Disorders of Human Immunodeficiency Virus Infection and Substance AbuseJag H Khalsa, Frank Vocci, Adrian Dobs
Journal of Addiction Medicine|September 26, 2014
Unobserved "home" induction onto buprenorphineJoshua D Lee, Frank Vocci, David A Fiellin
Substance Abuse|December 2, 2008
Comorbid psychiatric and substance abuse disorders: recent treatment researchPaula Riggs, Frances Levin, Alan I Green, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 14, 2007
Biotechnology and the treatment of addictive disorders: new opportunitiesAhmed Elkashef, Jamie Biswas, Jane B Acri, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Addiction (Abingdon, England)|June 8, 2012
Commentary on Elkashef et al. (2012): just enough efficacy for a second lookFrank Vocci
Addiction Biology|July 10, 2003
Biological markers of cocaine addiction: implications for medications developmentAhmed Elkashef, Frank Vocci
Pharmacology & Therapeutics|August 9, 2005
Medications development: successes and challengesFrank Vocci, Walter Ling
Journal of Addictive Diseases|August 7, 2008
Clinical management of drug addicts infected with human immunodeficiency virus and hepatitis C virusJag H Khalsa, Frank Vocci
Journal of Dual Diagnosis|September 28, 2011
Medications Development for the Treatment of Nicotine Dependence in Individuals with SchizophreniaIvan D Montoya, Frank Vocci
Current Psychiatry Reports|September 23, 2008
Novel medications to treat addictive disordersIván D Montoya, Frank Vocci
American Journal of Infectious Diseases|August 7, 2007
Hormonal and Metabolic Disorders of Human Immunodeficiency Virus Infection and Substance AbuseJag H Khalsa, Frank Vocci, Adrian Dobs
Journal of Addiction Medicine|September 26, 2014
Unobserved "home" induction onto buprenorphineJoshua D Lee, Frank Vocci, David A Fiellin
Substance Abuse|December 2, 2008
Comorbid psychiatric and substance abuse disorders: recent treatment researchPaula Riggs, Frances Levin, Alan I Green, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 14, 2007
Biotechnology and the treatment of addictive disorders: new opportunitiesAhmed Elkashef, Jamie Biswas, Jane B Acri, et al.
Pageof 4